Answers are grounded in this paper and cite their sources.
Experimental study demonstrates targeted gene upregulation using an RNA-guided transactivator in murine cells, highlighting a modular tool for gene control.
To promote expression of endogenous genes ad libitum, we developed a novel, programmable transcription factor prototype. Kept together via an MS2 coat protein/RNA interface, it includes a fixed, polypeptidic transactivating domain and a variable RNA domain that recognizes the desired gene. Thanks to this device, we specifically upregulated five genes, in cell lines and primary cultures of murine pallial precursors. Gene upregulation was small, however sufficient to robustly inhibit neuronal differentiation. The transactivator interacted with target gene chromatin via its RNA cofactor. Its activity was restricted to cells in which the target gene is normally transcribed. Our device might be useful for specific applications. However for this purpose, it will require an improvement of its transactivation power as well as a better characterization of its target specificity and mechanism of action.
No takes yet. Share an insight, caveat, or question.
Fimiani et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: